Literature DB >> 8291989

Effect of extending G-suit coverage on cardiovascular responses to positive pressure breathing.

L S Goodman1, W D Fraser, K N Ackles, D Mohn, M Pecaric.   

Abstract

The purpose of this study was to compare cardiovascular responses of subjects exposed to long-duration positive pressure breathing (PPB) while wearing a standard (Combat Edge; CE) vs. extended coverage (Tactical Life Support System; TLSS) G-suit. Twelve experienced subjects, wearing TLSS and CE, were separately exposed to counterbalanced 60, 70, 80, and 88 mm Hg PPB for up to 10 min continuously. Termination resulted if presyncopal symptoms arose. G-suit inflation was 4 x mask/jerkin pressure. Using TLSS, all subjects completed 10 min of PPB at all levels, vs. 7 and 5 subjects completing 10 min at 80 and 88 mm Hg, respectively, using the CE ensemble (p < 0.001). Heart rate was significantly elevated at all PPB levels using CE (p < 0.0001) vs. TLSS. Stroke and Cardiac Indexes were significantly lower with CE at all levels vs. TLSS (p < 0.0001), and mean arterial blood pressure failed to be maintained at the 80 and 88 PPB mm Hg levels using CE (p < 0.0001). Extended G-suits afford superior protection against PPB-induced cardiovascular dysfunction vs. standard ensembles and consequently permit use of higher levels of PPB. This is due to the larger and more uniform application of pressure in the leg G-suit bladders, augmenting venous return and stroke volume.

Entities:  

Mesh:

Year:  1993        PMID: 8291989

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  2 in total

1.  Effects of repeated exposure to acceleration forces (+Gz) and anti-G manoeuvres on cardiac dimensions and performance.

Authors:  Dan Carter; Alex Prokupetz; David Harpaz; Erez Barenboim
Journal:  Exp Clin Cardiol       Date:  2010

2.  Cardiovascular effects of anti-G suit inflation at 1 and 2 G.

Authors:  Stéphanie Montmerle; Dag Linnarsson
Journal:  Eur J Appl Physiol       Date:  2005-04-07       Impact factor: 3.078

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.